Miller Mary
SEC insider (Form 3/4/5 filer). CIK 0001841088. Chief Legal Officer at Acrivon Therapeutics, Inc. (ACRV). 25 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in WATERTOWN, MA.
Companies Miller Mary has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Officer, Chief Legal Officer
Miller Mary
CIK: 0001841088
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Acrivon Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Oct 22, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect513 shares at avg. $1.84$943.92 - Oct 5, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect294 shares at avg. $1.99$585.06 - Aug 18, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect185 shares at avg. $2.01$371.85 - Jul 21, 2026ACRV
Acrivon Therapeutics, Inc.
SaleDirect573 shares at avg. $1.76$1K - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect49.8K shares- - May 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect184 shares at avg. $1.92$353.28 - Apr 17, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect558 shares at avg. $1.78$993.24 - Mar 1, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
129.8K shares- - Feb 14, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect217 shares at avg. $1.63$353.71 - Jan 17, 2026ACRV
Acrivon Therapeutics, Inc.
Tax PaymentDirect659 shares at avg. $1.98$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 513 | $1.84 | $944 | Direct |
| Oct 5, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 294 | $1.99 | $585 | Direct |
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 185 | $2.01 | $372 | Direct |
| Jul 21, 2026 | ACRV Acrivon Therapeutics, Inc. | Sale | 573 | $1.76 | $1,008 | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 49,830 | - | $0 | Direct |
| May 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 184 | $1.92 | $353 | Direct |
| Apr 17, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 558 | $1.78 | $993 | Direct |
| Mar 1, 2026 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 129,760 | - | - | Direct |
| Feb 14, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 217 | $1.63 | $354 | Direct |
| Jan 17, 2026 | ACRV Acrivon Therapeutics, Inc. | Tax Payment | 659 | $1.98 | $1,305 | Direct |
1-10 of 25 transactions